nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—AR—duct of salivary gland—head and neck cancer	0.153	0.59	CbGeAlD
Testosterone Propionate—Oligospermia—Hydroxyurea—head and neck cancer	0.0439	0.092	CcSEcCtD
Testosterone Propionate—UGT1A1—Porphyrin metabolism—UROD—head and neck cancer	0.0385	0.146	CbGpPWpGaD
Testosterone Propionate—Azoospermia—Hydroxyurea—head and neck cancer	0.0341	0.0716	CcSEcCtD
Testosterone Propionate—Application site burn—Fluorouracil—head and neck cancer	0.0316	0.0662	CcSEcCtD
Testosterone Propionate—COMT—hair follicle—head and neck cancer	0.0177	0.0683	CbGeAlD
Testosterone Propionate—Application site pain—Fluorouracil—head and neck cancer	0.015	0.0315	CcSEcCtD
Testosterone Propionate—COMT—Estrogen metabolism—GSTM1—head and neck cancer	0.0126	0.0477	CbGpPWpGaD
Testosterone Propionate—COMT—Estrogen metabolism—CYP1A1—head and neck cancer	0.0119	0.0452	CbGpPWpGaD
Testosterone Propionate—CYP17A1—connective tissue—head and neck cancer	0.0116	0.0449	CbGeAlD
Testosterone Propionate—COMT—saliva-secreting gland—head and neck cancer	0.00925	0.0357	CbGeAlD
Testosterone Propionate—Neoplasm—Vinblastine—head and neck cancer	0.00911	0.0191	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptors—RARB—head and neck cancer	0.00865	0.0328	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—CEBPA—head and neck cancer	0.00852	0.0323	CbGpPWpGaD
Testosterone Propionate—Neoplasm—Hydroxyurea—head and neck cancer	0.00831	0.0174	CcSEcCtD
Testosterone Propionate—CYP17A1—thyroid gland—head and neck cancer	0.00772	0.0298	CbGeAlD
Testosterone Propionate—UGT1A1—Estrogen metabolism—GSTM1—head and neck cancer	0.00754	0.0286	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—NAT2—head and neck cancer	0.00716	0.0271	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Estrogen metabolism—CYP1A1—head and neck cancer	0.00715	0.0271	CbGpPWpGaD
Testosterone Propionate—COMT—trachea—head and neck cancer	0.00713	0.0276	CbGeAlD
Testosterone Propionate—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00698	0.0146	CcSEcCtD
Testosterone Propionate—CYP17A1—head—head and neck cancer	0.00685	0.0265	CbGeAlD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00683	0.0259	CbGpPWpGaD
Testosterone Propionate—Inflammation—Fluorouracil—head and neck cancer	0.00682	0.0143	CcSEcCtD
Testosterone Propionate—AR—connective tissue—head and neck cancer	0.00622	0.024	CbGeAlD
Testosterone Propionate—Breast disorder—Hydroxyurea—head and neck cancer	0.00603	0.0126	CcSEcCtD
Testosterone Propionate—AR—epithelium—head and neck cancer	0.0059	0.0228	CbGeAlD
Testosterone Propionate—COMT—thyroid gland—head and neck cancer	0.00564	0.0218	CbGeAlD
Testosterone Propionate—Dysuria—Hydroxyurea—head and neck cancer	0.00539	0.0113	CcSEcCtD
Testosterone Propionate—Weight increased—Hydroxyurea—head and neck cancer	0.00525	0.011	CcSEcCtD
Testosterone Propionate—Haemoglobin—Vinblastine—head and neck cancer	0.00509	0.0107	CcSEcCtD
Testosterone Propionate—Haemorrhage—Vinblastine—head and neck cancer	0.00506	0.0106	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00502	0.0105	CcSEcCtD
Testosterone Propionate—COMT—head—head and neck cancer	0.00501	0.0193	CbGeAlD
Testosterone Propionate—Inflammation—Docetaxel—head and neck cancer	0.00492	0.0103	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00486	0.0102	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.0048	0.0101	CcSEcCtD
Testosterone Propionate—CYP17A1—lymph node—head and neck cancer	0.00479	0.0185	CbGeAlD
Testosterone Propionate—Haemoglobin—Hydroxyurea—head and neck cancer	0.00464	0.00973	CcSEcCtD
Testosterone Propionate—Haemorrhage—Hydroxyurea—head and neck cancer	0.00462	0.00968	CcSEcCtD
Testosterone Propionate—Irritability—Fluorouracil—head and neck cancer	0.00458	0.00961	CcSEcCtD
Testosterone Propionate—AR—lymphoid tissue—head and neck cancer	0.00455	0.0176	CbGeAlD
Testosterone Propionate—Alopecia—Vinblastine—head and neck cancer	0.00447	0.00938	CcSEcCtD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00436	0.0165	CbGpPWpGaD
Testosterone Propionate—Neoplasm—Docetaxel—head and neck cancer	0.00432	0.00905	CcSEcCtD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.0043	0.0163	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—NAT2—head and neck cancer	0.00429	0.0163	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—NAT2—head and neck cancer	0.00419	0.0159	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Hydroxyurea—head and neck cancer	0.00419	0.00878	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.00414	0.0157	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—NAT2—head and neck cancer	0.00413	0.0157	CbGpPWpGaD
Testosterone Propionate—AR—thyroid gland—head and neck cancer	0.00413	0.016	CbGeAlD
Testosterone Propionate—Ill-defined disorder—Vinblastine—head and neck cancer	0.00409	0.00857	CcSEcCtD
Testosterone Propionate—Alopecia—Hydroxyurea—head and neck cancer	0.00408	0.00855	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—NAT2—head and neck cancer	0.00401	0.0152	CbGpPWpGaD
Testosterone Propionate—Malaise—Vinblastine—head and neck cancer	0.00397	0.00833	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—NAT2—head and neck cancer	0.00396	0.015	CbGpPWpGaD
Testosterone Propionate—Hypertension—Vinblastine—head and neck cancer	0.0038	0.00798	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00373	0.00782	CcSEcCtD
Testosterone Propionate—Discomfort—Vinblastine—head and neck cancer	0.00371	0.00777	CcSEcCtD
Testosterone Propionate—AR—head—head and neck cancer	0.00366	0.0142	CbGeAlD
Testosterone Propionate—Dermatitis bullous—Docetaxel—head and neck cancer	0.00363	0.0076	CcSEcCtD
Testosterone Propionate—Malaise—Hydroxyurea—head and neck cancer	0.00362	0.0076	CcSEcCtD
Testosterone Propionate—COMT—Phase II conjugation—GSTM1—head and neck cancer	0.00354	0.0134	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00354	0.0134	CbGpPWpGaD
Testosterone Propionate—COMT—lymph node—head and neck cancer	0.0035	0.0135	CbGeAlD
Testosterone Propionate—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00347	0.00727	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.0034	0.00712	CcSEcCtD
Testosterone Propionate—Discomfort—Hydroxyurea—head and neck cancer	0.00338	0.00709	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.00337	0.0128	CbGpPWpGaD
Testosterone Propionate—Haemoglobin—Fluorouracil—head and neck cancer	0.00334	0.007	CcSEcCtD
Testosterone Propionate—Haemorrhage—Fluorouracil—head and neck cancer	0.00332	0.00697	CcSEcCtD
Testosterone Propionate—Oedema—Hydroxyurea—head and neck cancer	0.00328	0.00688	CcSEcCtD
Testosterone Propionate—Paraesthesia—Vinblastine—head and neck cancer	0.00323	0.00677	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00322	0.00674	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Docetaxel—head and neck cancer	0.0032	0.00671	CcSEcCtD
Testosterone Propionate—Skin disorder—Hydroxyurea—head and neck cancer	0.00318	0.00668	CcSEcCtD
Testosterone Propionate—Breast disorder—Docetaxel—head and neck cancer	0.00313	0.00657	CcSEcCtD
Testosterone Propionate—Pain—Vinblastine—head and neck cancer	0.00307	0.00645	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—NOTCH1—head and neck cancer	0.00299	0.0113	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Vinblastine—head and neck cancer	0.00296	0.00621	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00294	0.00616	CcSEcCtD
Testosterone Propionate—Alopecia—Fluorouracil—head and neck cancer	0.00294	0.00616	CcSEcCtD
Testosterone Propionate—Dyspnoea—Hydroxyurea—head and neck cancer	0.00292	0.00613	CcSEcCtD
Testosterone Propionate—Abdominal pain—Vinblastine—head and neck cancer	0.00284	0.00596	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00283	0.00594	CcSEcCtD
Testosterone Propionate—Fatigue—Hydroxyurea—head and neck cancer	0.00283	0.00593	CcSEcCtD
Testosterone Propionate—Pain—Hydroxyurea—head and neck cancer	0.0028	0.00588	CcSEcCtD
Testosterone Propionate—Weight increased—Docetaxel—head and neck cancer	0.00273	0.00572	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Hydroxyurea—head and neck cancer	0.0027	0.00567	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Vinblastine—head and neck cancer	0.00265	0.00555	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.00261	0.00989	CbGpPWpGaD
Testosterone Propionate—Asthenia—Vinblastine—head and neck cancer	0.00258	0.00541	CcSEcCtD
Testosterone Propionate—AR—lymph node—head and neck cancer	0.00256	0.00991	CbGeAlD
Testosterone Propionate—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00253	0.0053	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—NAT2—head and neck cancer	0.00251	0.00951	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—NAT2—head and neck cancer	0.00247	0.00938	CbGpPWpGaD
Testosterone Propionate—Myalgia—Fluorouracil—head and neck cancer	0.00246	0.00516	CcSEcCtD
Testosterone Propionate—Diarrhoea—Vinblastine—head and neck cancer	0.00246	0.00516	CcSEcCtD
Testosterone Propionate—UGT1A1—NRF2 pathway—TGFA—head and neck cancer	0.00243	0.00922	CbGpPWpGaD
Testosterone Propionate—Discomfort—Fluorouracil—head and neck cancer	0.00243	0.0051	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00242	0.00507	CcSEcCtD
Testosterone Propionate—Haemoglobin—Docetaxel—head and neck cancer	0.00241	0.00505	CcSEcCtD
Testosterone Propionate—Haemorrhage—Docetaxel—head and neck cancer	0.0024	0.00503	CcSEcCtD
Testosterone Propionate—Confusional state—Fluorouracil—head and neck cancer	0.00238	0.00499	CcSEcCtD
Testosterone Propionate—Dizziness—Vinblastine—head and neck cancer	0.00238	0.00499	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00238	0.009	CbGpPWpGaD
Testosterone Propionate—Urinary tract disorder—Docetaxel—head and neck cancer	0.00237	0.00497	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00236	0.00495	CcSEcCtD
Testosterone Propionate—Oedema—Fluorouracil—head and neck cancer	0.00236	0.00495	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Docetaxel—head and neck cancer	0.00236	0.00494	CcSEcCtD
Testosterone Propionate—Asthenia—Hydroxyurea—head and neck cancer	0.00235	0.00493	CcSEcCtD
Testosterone Propionate—Urethral disorder—Docetaxel—head and neck cancer	0.00235	0.00493	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Fluorouracil—head and neck cancer	0.00231	0.00485	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—MAPK3—head and neck cancer	0.00231	0.00875	CbGpPWpGaD
Testosterone Propionate—Vomiting—Vinblastine—head and neck cancer	0.00229	0.00479	CcSEcCtD
Testosterone Propionate—Headache—Vinblastine—head and neck cancer	0.00225	0.00472	CcSEcCtD
Testosterone Propionate—Diarrhoea—Hydroxyurea—head and neck cancer	0.00224	0.0047	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CASP8—head and neck cancer	0.00221	0.00838	CbGpPWpGaD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—MAPK1—head and neck cancer	0.0022	0.00832	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Docetaxel—head and neck cancer	0.00218	0.00456	CcSEcCtD
Testosterone Propionate—Dizziness—Hydroxyurea—head and neck cancer	0.00217	0.00455	CcSEcCtD
Testosterone Propionate—Immune system disorder—Docetaxel—head and neck cancer	0.00217	0.00454	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00216	0.00819	CbGpPWpGaD
Testosterone Propionate—Mediastinal disorder—Docetaxel—head and neck cancer	0.00216	0.00453	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00215	0.00451	CcSEcCtD
Testosterone Propionate—Nausea—Vinblastine—head and neck cancer	0.00214	0.00448	CcSEcCtD
Testosterone Propionate—Insomnia—Fluorouracil—head and neck cancer	0.00213	0.00448	CcSEcCtD
Testosterone Propionate—Paraesthesia—Fluorouracil—head and neck cancer	0.00212	0.00444	CcSEcCtD
Testosterone Propionate—Alopecia—Docetaxel—head and neck cancer	0.00212	0.00444	CcSEcCtD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTM1—head and neck cancer	0.00212	0.00803	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Fluorouracil—head and neck cancer	0.0021	0.00441	CcSEcCtD
Testosterone Propionate—Mental disorder—Docetaxel—head and neck cancer	0.0021	0.0044	CcSEcCtD
Testosterone Propionate—Malnutrition—Docetaxel—head and neck cancer	0.00209	0.00438	CcSEcCtD
Testosterone Propionate—Vomiting—Hydroxyurea—head and neck cancer	0.00208	0.00437	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—GSTM1—head and neck cancer	0.00207	0.00784	CbGpPWpGaD
Testosterone Propionate—Rash—Hydroxyurea—head and neck cancer	0.00207	0.00434	CcSEcCtD
Testosterone Propionate—Dermatitis—Hydroxyurea—head and neck cancer	0.00207	0.00433	CcSEcCtD
Testosterone Propionate—Headache—Hydroxyurea—head and neck cancer	0.00205	0.00431	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—GSTM1—head and neck cancer	0.00204	0.00773	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00204	0.00427	CcSEcCtD
Testosterone Propionate—Pain—Fluorouracil—head and neck cancer	0.00202	0.00423	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTM1—head and neck cancer	0.00198	0.00751	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP1A1—head and neck cancer	0.00196	0.00743	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.00195	0.00741	CbGpPWpGaD
Testosterone Propionate—Nausea—Hydroxyurea—head and neck cancer	0.00195	0.00408	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Fluorouracil—head and neck cancer	0.00194	0.00408	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00193	0.00733	CbGpPWpGaD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—PIK3CA—head and neck cancer	0.00191	0.00722	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP1A1—head and neck cancer	0.00188	0.00712	CbGpPWpGaD
Testosterone Propionate—Urticaria—Fluorouracil—head and neck cancer	0.00187	0.00393	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.00186	0.00705	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00185	0.00702	CbGpPWpGaD
Testosterone Propionate—Hypertension—Docetaxel—head and neck cancer	0.0018	0.00378	CcSEcCtD
Testosterone Propionate—Arthralgia—Docetaxel—head and neck cancer	0.00178	0.00373	CcSEcCtD
Testosterone Propionate—Myalgia—Docetaxel—head and neck cancer	0.00178	0.00373	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00176	0.0037	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—HRAS—head and neck cancer	0.00176	0.00668	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—head and neck cancer	0.00176	0.00667	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Fluorouracil—head and neck cancer	0.00174	0.00365	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—STAT3—head and neck cancer	0.00173	0.00656	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—UROD—head and neck cancer	0.00173	0.00654	CbGpPWpGaD
Testosterone Propionate—Confusional state—Docetaxel—head and neck cancer	0.00172	0.0036	CcSEcCtD
Testosterone Propionate—Oedema—Docetaxel—head and neck cancer	0.0017	0.00357	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Docetaxel—head and neck cancer	0.0017	0.00357	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Docetaxel—head and neck cancer	0.00167	0.0035	CcSEcCtD
Testosterone Propionate—Pruritus—Fluorouracil—head and neck cancer	0.00167	0.0035	CcSEcCtD
Testosterone Propionate—Skin disorder—Docetaxel—head and neck cancer	0.00165	0.00347	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—UROD—head and neck cancer	0.00165	0.00626	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CCND1—head and neck cancer	0.00163	0.00617	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Fluorouracil—head and neck cancer	0.00161	0.00339	CcSEcCtD
Testosterone Propionate—Dizziness—Fluorouracil—head and neck cancer	0.00156	0.00327	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—AKT1—head and neck cancer	0.00156	0.0059	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00155	0.00325	CcSEcCtD
Testosterone Propionate—Insomnia—Docetaxel—head and neck cancer	0.00154	0.00323	CcSEcCtD
Testosterone Propionate—Paraesthesia—Docetaxel—head and neck cancer	0.00153	0.00321	CcSEcCtD
Testosterone Propionate—Dyspnoea—Docetaxel—head and neck cancer	0.00152	0.00318	CcSEcCtD
Testosterone Propionate—Vomiting—Fluorouracil—head and neck cancer	0.0015	0.00315	CcSEcCtD
Testosterone Propionate—Rash—Fluorouracil—head and neck cancer	0.00149	0.00312	CcSEcCtD
Testosterone Propionate—Dermatitis—Fluorouracil—head and neck cancer	0.00149	0.00312	CcSEcCtD
Testosterone Propionate—Headache—Fluorouracil—head and neck cancer	0.00148	0.0031	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00147	0.00308	CcSEcCtD
Testosterone Propionate—Fatigue—Docetaxel—head and neck cancer	0.00147	0.00308	CcSEcCtD
Testosterone Propionate—Pain—Docetaxel—head and neck cancer	0.00146	0.00305	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.00142	0.00539	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSTM1—head and neck cancer	0.00141	0.00536	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Docetaxel—head and neck cancer	0.0014	0.00294	CcSEcCtD
Testosterone Propionate—Nausea—Fluorouracil—head and neck cancer	0.0014	0.00294	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00139	0.00292	CcSEcCtD
Testosterone Propionate—Abdominal pain—Docetaxel—head and neck cancer	0.00135	0.00282	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—head and neck cancer	0.00131	0.00497	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.0013	0.00492	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00128	0.00486	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Docetaxel—head and neck cancer	0.00126	0.00263	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTM1—head and neck cancer	0.00124	0.0047	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.00122	0.00463	CbGpPWpGaD
Testosterone Propionate—Asthenia—Docetaxel—head and neck cancer	0.00122	0.00256	CcSEcCtD
Testosterone Propionate—Pruritus—Docetaxel—head and neck cancer	0.00121	0.00253	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CCND1—head and neck cancer	0.0012	0.00456	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—RARB—head and neck cancer	0.00118	0.00447	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP1A1—head and neck cancer	0.00117	0.00445	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Docetaxel—head and neck cancer	0.00117	0.00244	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—PTEN—head and neck cancer	0.00116	0.0044	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00116	0.00439	CbGpPWpGaD
Testosterone Propionate—Dizziness—Docetaxel—head and neck cancer	0.00113	0.00236	CcSEcCtD
Testosterone Propionate—Vomiting—Docetaxel—head and neck cancer	0.00108	0.00227	CcSEcCtD
Testosterone Propionate—Rash—Docetaxel—head and neck cancer	0.00107	0.00225	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—YAP1—head and neck cancer	0.00107	0.00407	CbGpPWpGaD
Testosterone Propionate—Dermatitis—Docetaxel—head and neck cancer	0.00107	0.00225	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.00107	0.00406	CbGpPWpGaD
Testosterone Propionate—Headache—Docetaxel—head and neck cancer	0.00107	0.00224	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.00106	0.00401	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—STAT3—head and neck cancer	0.00104	0.00394	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—UROD—head and neck cancer	0.00103	0.00392	CbGpPWpGaD
Testosterone Propionate—Nausea—Docetaxel—head and neck cancer	0.00101	0.00212	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—EGFR—head and neck cancer	0.000944	0.00358	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000919	0.00348	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—AKT1—head and neck cancer	0.000906	0.00343	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000887	0.00336	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000789	0.00299	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000761	0.00289	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000761	0.00289	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000733	0.00278	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000729	0.00276	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000723	0.00274	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000722	0.00274	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000721	0.00273	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NAT2—head and neck cancer	0.000716	0.00272	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000688	0.00261	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NAT2—head and neck cancer	0.000686	0.0026	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.00067	0.00254	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—AKT1—head and neck cancer	0.00067	0.00254	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000653	0.00248	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000631	0.00239	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—DPYD—head and neck cancer	0.000628	0.00238	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000619	0.00235	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000619	0.00235	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—DPYD—head and neck cancer	0.000602	0.00228	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—YAP1—head and neck cancer	0.000596	0.00226	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000588	0.00223	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—YAP1—head and neck cancer	0.000571	0.00216	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.00057	0.00216	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—RARB—head and neck cancer	0.000568	0.00215	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—MAPK1—head and neck cancer	0.000562	0.00213	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000539	0.00204	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000519	0.00197	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—YAP1—head and neck cancer	0.000517	0.00196	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000513	0.00194	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000513	0.00194	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000484	0.00183	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—HRAS—head and neck cancer	0.000451	0.00171	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000445	0.00169	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000439	0.00166	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.00043	0.00163	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NAT2—head and neck cancer	0.000429	0.00163	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000429	0.00163	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—DPYD—head and neck cancer	0.000376	0.00143	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000374	0.00142	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000363	0.00138	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TYMS—head and neck cancer	0.000358	0.00136	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—YAP1—head and neck cancer	0.000357	0.00135	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTM1—head and neck cancer	0.000354	0.00134	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TYMS—head and neck cancer	0.000343	0.0013	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTM1—head and neck cancer	0.000339	0.00128	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GPX1—head and neck cancer	0.000339	0.00128	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP1A1—head and neck cancer	0.000335	0.00127	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GPX1—head and neck cancer	0.000324	0.00123	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP1A1—head and neck cancer	0.000321	0.00122	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000264	0.001	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NOTCH1—head and neck cancer	0.000233	0.000883	CbGpPWpGaD
Testosterone Propionate—Drospirenone—PTGS2—head and neck cancer	0.000227	0.455	CrCbGaD
Testosterone Propionate—UGT1A1—Metabolism—TYMS—head and neck cancer	0.000214	0.000813	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTM1—head and neck cancer	0.000212	0.000803	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GPX1—head and neck cancer	0.000203	0.000769	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP1A1—head and neck cancer	0.000201	0.000762	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTGS2—head and neck cancer	0.000199	0.000756	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTGS2—head and neck cancer	0.000191	0.000724	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTEN—head and neck cancer	0.000174	0.000659	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTEN—head and neck cancer	0.000167	0.000631	CbGpPWpGaD
Testosterone Propionate—Progesterone—CYP1A1—head and neck cancer	0.00014	0.28	CrCbGaD
Testosterone Propionate—Testosterone—CYP1A1—head and neck cancer	0.000132	0.265	CrCbGaD
Testosterone Propionate—AR—Gene Expression—MAPK3—head and neck cancer	0.000129	0.000489	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CA—head and neck cancer	0.000123	0.000465	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTGS2—head and neck cancer	0.000119	0.000453	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CA—head and neck cancer	0.000118	0.000445	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTEN—head and neck cancer	0.000104	0.000395	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—AKT1—head and neck cancer	0.0001	0.00038	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKT1—head and neck cancer	9.6e-05	0.000364	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—AKT1—head and neck cancer	8.69e-05	0.00033	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CA—head and neck cancer	7.35e-05	0.000279	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKT1—head and neck cancer	6.01e-05	0.000228	CbGpPWpGaD
